Recently, the immune evasion induced via the combination of Programmed Cell Death Protein 1 (PD-1) and Programmed Cell Death Protein-ligand 1 (PD-L1) has become an impactive target for tumor cure, bringing a new direction for advanced LC therapy [3]. The gene discussed is PDCD1; the disease is neoplasm.